Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone versus placebo in idiopathic pulmonary fibrosis
IRCT2017031333044N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in idiopathic pulmonary fibrosis (IPF) comparing Pirfenidone arm with Placebo arm (2 arms). Started Mar 2014; status: completed.
02
Drugs
pirfenidone
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on IRCT2017031333044N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017031333044N1.